Page 56 - IJB-10-5
P. 56

International Journal of Bioprinting                                  Medical regenerative in situ bioprinting




               Bioprinting is increasingly demanded due to conditions   tomography (CT), before printing and transplantation to
            such as osteosarcoma,  osteoporosis,  and skin     the wound site, but the time-consuming nature of MRI
                                              7,8
                                 5,6
            burns. 9–11  Given the complex hierarchical architectures   or CT scanning makes this approach challenging for
                                                                                      23
            of human organs and the individual differences among   time-sensitive clinical cases ; (ii) the printed scaffolds
            patients, conventional tissue engineering strategies fail to   may deform or contract after implantation, making it
                                                                                                  2
            fabricate scaffolds with controlled surface chemistry and   challenging to precisely match the defects ; (iii) before
            complex  microstructure. 12,13   Bioprinting  can construct   surgical implantation, the scaffold requires  in vitro
                                                                                           24
            artificial tissue grafts with precise cell and regenerative   maturation that lasts several weeks.  Hence, it is necessary
            factor  placements,  overcoming  the limitations  of donor   to overcome these barriers in 3D bioprinting to meet the
            availability.  Bioprinting is also widely used to create tissue   needs of emergency clinical applications. 25
                     14
            models for drug testing 15–18   and disease modeling. 19–22    Conversely, in situ, bioprinting, introduced in 2007 as
            However, there are still limitations that hinder its   an emerging strategy for clinical translation of bioprinting,
            development: (i) conventional bioprinting strategies   has recently gained traction. 26,27  This technology, also called
            require a computer-aided design (CAD) model, generated   intraoperative bioprinting, directly prints biomaterials
            by magnetic resonance imaging (MRI) or X-ray computed   inside tissue defects. 28,29   In situ bioprinting bypasses  in






















































            Figure 1. Schematic diagrams of (A) robotic-assisted in situ bioprinting system (RASBS) and (B) handheld in situ bioprinting system (HISBS). Adapted,
            with permission, from Levin et al.  (A) and Cheng et al.  (B).
                                 34
                                                9
            Volume 10 Issue 5 (2024)                        48                                doi: 10.36922/ijb.3366
   51   52   53   54   55   56   57   58   59   60   61